TY - JOUR
T1 - Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities
AU - Candelario-Jalil, Eduardo
AU - Dijkhuizen, Rick M.
AU - Magnus, Tim
N1 - Funding Information:
Dr Candelario-Jalil receives support from the National Institute of Neurological Disorders and Stroke, grants R01NS103094 and R01NS109816. Dr Dijkhuizen is a member of the CONTRAST (Collaboration for New Treatments of Acute Stroke) consortium, which acknowledges the support from the Netherlands Cardiovascular Research Initiative—an initiative of the Dutch Heart Foundation (CVON2015-01: CONTRAST)—and from the Brain Foundation Netherlands (HA2015.01.06). Dr Magnus was supported by grants from the Deutsche Forschungsgemeinschaft (FOR 2879 A1 MA 4375/5-1, A3 MA 4375/6-1, A13 of the SFB 1328) and the Schilling Stiftung.
Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/5/1
Y1 - 2022/5/1
N2 - Maintaining blood-brain barrier (BBB) integrity is crucial for the homeostasis of the central nervous system. Structurally comprising the BBB, brain endothelial cells interact with pericytes, astrocytes, neurons, microglia, and perivascular macrophages in the neurovascular unit. Brain ischemia unleashes a profound neuroinflammatory response to remove the damaged tissue and prepare the brain for repair. However, the intense neuroinflammation occurring during the acute phase of stroke is associated with BBB breakdown, neuronal injury, and worse neurological outcomes. Here, we critically discuss the role of neuroinflammation in ischemic stroke pathology, focusing on the BBB and the interactions between central nervous system and peripheral immune responses. We highlight inflammation-driven injury mechanisms in stroke, including oxidative stress, increased MMP (matrix metalloproteinase) production, microglial activation, and infiltration of peripheral immune cells into the ischemic tissue. We provide an updated overview of imaging techniques for in vivo detection of BBB permeability, leukocyte infiltration, microglial activation, and upregulation of cell adhesion molecules following ischemic brain injury. We discuss the possibility of clinical implementation of imaging modalities to assess stroke-associated neuroinflammation with the potential to provide image-guided diagnosis and treatment. We summarize the results from several clinical studies evaluating the efficacy of anti-inflammatory interventions in stroke. Although convincing preclinical evidence suggests that neuroinflammation is a promising target for ischemic stroke, thus far, translating these results into the clinical setting has proved difficult. Due to the dual role of inflammation in the progression of ischemic damage, more research is needed to mechanistically understand when the neuroinflammatory response begins the transition from injury to repair. This could have important implications for ischemic stroke treatment by informing time- and context-specific therapeutic interventions.
AB - Maintaining blood-brain barrier (BBB) integrity is crucial for the homeostasis of the central nervous system. Structurally comprising the BBB, brain endothelial cells interact with pericytes, astrocytes, neurons, microglia, and perivascular macrophages in the neurovascular unit. Brain ischemia unleashes a profound neuroinflammatory response to remove the damaged tissue and prepare the brain for repair. However, the intense neuroinflammation occurring during the acute phase of stroke is associated with BBB breakdown, neuronal injury, and worse neurological outcomes. Here, we critically discuss the role of neuroinflammation in ischemic stroke pathology, focusing on the BBB and the interactions between central nervous system and peripheral immune responses. We highlight inflammation-driven injury mechanisms in stroke, including oxidative stress, increased MMP (matrix metalloproteinase) production, microglial activation, and infiltration of peripheral immune cells into the ischemic tissue. We provide an updated overview of imaging techniques for in vivo detection of BBB permeability, leukocyte infiltration, microglial activation, and upregulation of cell adhesion molecules following ischemic brain injury. We discuss the possibility of clinical implementation of imaging modalities to assess stroke-associated neuroinflammation with the potential to provide image-guided diagnosis and treatment. We summarize the results from several clinical studies evaluating the efficacy of anti-inflammatory interventions in stroke. Although convincing preclinical evidence suggests that neuroinflammation is a promising target for ischemic stroke, thus far, translating these results into the clinical setting has proved difficult. Due to the dual role of inflammation in the progression of ischemic damage, more research is needed to mechanistically understand when the neuroinflammatory response begins the transition from injury to repair. This could have important implications for ischemic stroke treatment by informing time- and context-specific therapeutic interventions.
KW - blood-brain barrier
KW - immunity
KW - ischemic stroke
KW - microglia
KW - neuroinflammatory diseases
UR - http://www.scopus.com/inward/record.url?scp=85129267372&partnerID=8YFLogxK
U2 - 10.1161/STROKEAHA.122.036946
DO - 10.1161/STROKEAHA.122.036946
M3 - Review article
C2 - 35387495
AN - SCOPUS:85129267372
SN - 0039-2499
VL - 53
SP - 1473
EP - 1486
JO - Stroke
JF - Stroke
IS - 5
ER -